GSP Crop Science Q2 FY27: PAT ₹26.4 & Rev ₹386 Cr

Metric	Value
Revenue	₹386 Cr
Net Profit (PAT)	₹26.4

📢 Key Event
Q1 FY27 PAT up 16% to INR 26.4 crores on specialty product mix gains

🔄 What Changed
PAT growth of 16%, EBITDA margin target raised to 13-14%, patented product share growth target doubled within 3 years

🔮 What's Next
15% revenue growth target, EBITDA margin expansion to 13-14% over next 2-3 years, patented product share to double in 3 years

💡 Investor Takeaway
Shareholders should note PAT growth is accelerating due to higher-margin patented products and cost management, with international markets expected to contribute meaningfully in H2.

GSP Crop Science reported Q1 FY27 revenue of INR 386 crores with PAT rising 16% to INR 26.4 crores, driven by improved gross margins from specialty products and patented formulations. Export revenue contributed 10% of total sales, with overseas markets showing early demand recovery in Brazil ahead of the H2 season. The company highlighted backward integration progress at Dahej and Saykha facilities, targeting double-digit patented product growth within three years, and projected 15% revenue expansion with EBITDA margins reaching 13-14% by year-end. Domestic revenue split stands at 80% (50% B2C, 30% B2B), supported by rising farmer adoption of preventive spraying and specialty chemicals. Other income included a one-time INR23 crore land sale gain, with no further non-core asset disposals anticipated.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GSPCROP ✨ Ask AI About This

About GSP Crop Science Limited (GSPCROP)

Chemicals · Agro Chemicals · Listed on NSE

Market Cap: ₹2,975.57 Cr P/E: 26.0 ROE: 21.9% ROCE: 22.5% Div Yield: 0.16%

View full GSPCROP stock details →

📡 Get AI alerts when GSPCROP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GSPCROP — Free

💡 Ask AI about this filing

"How will Brazil demand recovery specifically impact Q3 revenue?" "What is the timeline for repaying the remaining IPO-linked loan amount?" "When will the next patented formulation be launched commercially?"

Ask AI Free →

📊 More GSPCROP filings

See all GSPCROP filings →

🔥 Also filed on 17 August 2026

PREMIERENE Premier Energies Limited Announcement ABCAPITAL Aditya Birla Capital Limited Corporate Action VIVIMEDLAB Vivimed Labs Limited Announcement SEDEMAC SEDEMAC Mechatronics Limited Annual Report AFFLE Affle 3i Limited Financial Results FERMENTA Fermenta Biotech Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GSPCROP files new disclosures

Track GSPCROP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GSPCROP — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd